BHEL has secured a ₹6,700 crore contract from Singareni Collieries to establish an 800 MW thermal power unit in Telangana. The project will strengthen India’s energy security and support self-reliance.
Shares of Dr. Agarwal’s Health Care ended 3.1% lower at ₹435 on Friday. The stock, however, has risen more than 10% in this week and a little over 8% since its listing.
Mahanagar Telephone Nigam Ltd (MTNL) reported a net loss of ₹836 crore in Q3 FY24, slightly lower than the ₹839 crore loss a year ago. Revenue fell 11.6%, while EBITDA loss widened to ₹128.1 crore.
Voluntary action indicated (VAI) is suggested when violations are found, but the problems do not justify further regulatory action. Shares of Alembic Pharmaceuticals Ltd ended at ₹809, down by ₹17.20, or 2.08%, on the BSE.
Aditya Birla Fashion and Retail Ltd (ABFRL) posted a net loss of ₹51.3 crore in Q3 FY24, improving from a ₹77.9 crore loss last year.
The EBITDA margin stood at 22.5%, less than 100 bps below 23.2% in the third quarter of FY24. Shares of Narayana Hrudayalaya Ltd ended at ₹1,335, up ₹5.75, or 0.43%, on the BSE.
EBITDA zoomed to ₹600.3 crore in the third quarter over a loss of ₹208.7 crore in the year-ago quarter. Shares of Glenmark Pharmaceuticals Ltd ended at ₹1,321.35, down by ₹88.55, or 6.28%, on the BSE.
Shares of Dilip Buildcon ended 3.3% lower at ₹393.40 on Friday.
Zydus Lifesciences’ US formulation sales for the third quarter stood at $285 million, which is a growth of 29% on a year-on-year basis. Shares of Zydus Lifesciences Ltd ended at ₹901.60, down by ₹40.85, or 4.33%, on the BSE.
RBI clarified that the penalty was imposed due to regulatory deficiencies and did not impact the validity of the company’s transactions with its customers. Shares of Shriram Finance Ltd ended at ₹539.05, down by ₹9.20, or 1.68%, on the BSE.